Analysis of perioperative factors in the development of early Fontan failure : a single-center experience
Öz
ABSTRACT
Aim
Early Fontan failure (EFF) after Fontan surgery is rarely observed. Examining perioperative factors associated with this complication, which can lead to mortality and morbidity , is crucial for early diagnosis and treatment.
Material and Methods
All pediatric patients who underwent Fontan surgery between 2019 and 2023 were retrospectively analyzed. Preoperative demographic, echocardiographic, and angiographic data were collected. Hospital data related to operative and postoperative variables were retrospectively examined. The relationship between these variables and the development of EFF was investigated.
Results
A total of 21 Fontan patients were included in this study, and 10 of them (47.6%) developed EFF. Postoperatively, three patients (14.2%) died. Of the patients, 52.4% were male, with a median age of 4.5 years. Among the findings, postoperative maximum vasoactive-inotropic score (maxVIS) within the first 24 postoperative hour (p=0.023) and initial blood gas lactate values (p=0,019) were significantly higher in patient who developed EFF. Furthermore, the need for renal replacement therapy (p=0.020) and extracorporeal membrane oxygenation (ECMO) (p=0.020) were found to be associated with EFF. Delay in extubation due to hemodynamic instability has been identified as a significant risk factor for the development of EFF.
Conclusion
The postoperative maxVIS value in postoperative 24 hour and initial lactate levels in intensive care unit were found to be associated with EFF development. Delay in extubation due to hemodynamic instability has been identified as a significant risk factor for the development of EFF.
Anahtar Kelimeler
Kaynakça
- 1. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax 1971; 26: 240- 8.
- 2. d’Udekem Y, Iyengar AJ, Cochrane AD, Grigg LE, Ramsay JM, Wheaton GR, et al. The Fontan procedure: Contemporary techniques have improved long-term outcomes. Circulation 2007; 116: I-157-I-64.
- 3. Gewillig M, Brown SC. The Fontan circulation after 45 years: update in physiology. Heart 2016; 102: 1081-6.
- 4. Mazza GA, Gribaudo E, Agnoletti G. The pathophysiology and complications of Fontan circulation. Acta Bio Medica: Atenei Parmensis 2021; 92.
- 5. Mery CM, De León LE, Trujillo-Diaz D, Ocampo EC, Dickerson HA, Zhu H, et al. Contemporary outcomes of the Fontan operation: a large single-institution cohort. Ann Thorac Surg 2019; 108: 1439-46.
- 6. d’Udekem Y, Iyengar AJ, Galati JC, Forsdick V, Weintraub RG, Wheaton GR, et al. Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation 2014; 130: S32-S8.
- 7. Venna A, Cetta F, d'Udekem Y. Fontan candidacy, optimizing Fontan circulation, and beyond. JTCVS open 2022; 9: 227-32.
- 8. Kotani Y, Chetan D, Zhu J, Saedi A, Zhao L, Mertens L, et al. Fontan failure and death in contemporary Fontan circulation: analysis from the last two decades. Ann Thorac Surg 2018; 105: 1240-7.
- 9. Marathe SP, Cao JY, Celermajer D, Ayer J, Sholler GF, d’Udekem Y, et al. Outcomes of the Fontan operation for patients with heterotaxy: a meta-analysis of 848 patients. Ann Thorac Surg 2020; 110: 307-15.
- 10. Podzolkov VP, Chiaureli MR, Yurlov IA, Zelenikin MM, Kovalev DV, Dontsova VI, et al. Results of Fontan operation in patients with atrioventricular valve regurgitation. Eur J Cardiothorac Surg 2015; 48: 308-15.